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The incidence and clinical presentation of infantile rotavirus 
diarrhoea in Sierra Leone
François P R de Villiers, Thomas N Sawyerr, Gillian K de Villiers 
Rotaviruses occur widely among humans and many animal 
species throughout the world, and are important causes 
of gastroenteritis. Since their discovery over 30 years ago 
human rotaviruses have been shown to be the major cause of 
paediatric diarrhoeal disease morbidity and mortality.1
The virus will have infected some 90% of children by the 
age of 3 and practically all children by the age of 5,2 and 
accounts for approximately 600 000 deaths worldwide every 
year.3 The incidence of rotavirus disease in children is similar 
in developed and developing countries, but mortality from 
diarrhoeal disease is higher in the latter, predominantly 
owing to poor knowledge of oral rehydration therapy and 
malnutrition. In Africa rotavirus accounts for about a quarter 
of hospitalisations of children for diarrhoea.4,5 A study from 
15 African countries done to assess epidemiology and disease 
burden suggests that rotavirus is the most important cause of 
severe diarrhoea in African children.4 Public health measures to 
provide clean water and improved hygiene and sanitation may 
affect the incidence of diarrhoea caused by bacterial infection, 
but not that of rotavirus.4 Vaccines have been shown to be 
the only means of reducing morbidity and mortality due to 
rotavirus.1,5,6 In industrialised countries with good standards 
of hygiene and clean food and water rotavirus remains the 
most common cause of diarrhoea-associated hospitalisations 
among young children.3 There is an urgent need to develop an 
effective vaccine to protect against severe rotavirus disease, and 
data on the incidence of rotavirus infections in Africa and the 
antigenic and genomic diversity of the rotavirus are required 
for the design of an effective vaccine strategy.
Since no rotavirus incidence studies have been done in Sierra 
Leone, this study was designed to determine the epidemiology 
of rotavirus infections in that country to inform policy makers 
on the need for the introduction of new rotavirus vaccines.
Methodology
This descriptive study of children between the ages of 3 and 
30 months admitted with gastroenteritis was conducted at the 
Ola During Children’s Hospital, the main paediatric referral 
hospital in Sierra Leone.
The target enrolment was 40 cases per month for a period 
of 5 months during the diarrhoea season.  Children with 
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Objectives. An effective vaccine is needed to protect against 
severe rotavirus disease, an important cause of gastroenteritis. 
Since there are no data on the incidence and antigenic 
diversity of rotavirus infection in Sierra Leone, we studied 
its epidemiology to enable an effective vaccine strategy to be 
designed. 
Methods. Children between the ages of 3 and 30 months 
presenting with gastroenteritis to the Ola During Children’s 
Hospital in Freetown, Sierra Leone, were enrolled. Stool 
specimens were tested in South Africa using polyacrylamide 
gel electrophoresis to confirm rotavirus infection.
Results. Over a 5-month period 143 children presenting with 
gastroenteritis were recruited. Stool samples obtained from 
128 study subjects were tested for the presence of rotavirus; 
45% were aged between 3 and 9 months (mean age 10.85 
months), and 48 stool samples (37.5%) tested positive for 
rotavirus. The incidence of rotavirus infection was 20% higher 
in boys than in girls, a gender difference confirmed elsewhere 
in West Africa. The prevalence of rotavirus-positive stools 
peaked in August, coinciding with the rainy season. About 
90% of the rotavirus-positive patients had severe diarrhoea, 
as opposed to only about two-thirds of the patients whose 
diarrhoea was not caused by rotavirus; this difference was 
statistically significant.
Conclusions. There is a high incidence of rotavirus 
infection in Sierra Leone, with rotavirus causing 37.5% of 
the gastroenteritis in this study. Patients with rotavirus 
gastroenteritis almost all had severe diarrhoea. The high 
incidence of rotavirus infection and the severity of the disease 
presentation make the institution of a rotavirus vaccine 
programme in Sierra Leone imperative. 
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dysentery (bloody diarrhoea or bloodstained stools) were 
excluded. On admission the relevant demographic data and 
history with regard to onset, duration and severity of the 
presenting complaints were obtained from the parents. Clinical 
data, including anthropometric measurements, were recorded 
on a data sheet. 
Specimens were obtained by collecting stools from each 
study subject and were screened in Sierra Leone (by TNS) 
for the presence of rotavirus antigen using Rota-Strip 
(CORIS BioConcept), an immunochromatographic test for 
rotavirus detection in stool specimens. The samples were also 
tested in the laboratory in South Africa (by GKdeV) using 
polyacrylamide gel electrophoresis (PAGE) to confirm rotavirus 
infection and to screen for non-A rotaviruses. The PAGE gel 
results were used during the data analysis unless the results 
were indeterminate, when the CORIS results were used.
A pilot study of 15 cases conducted at Medunsa and 5 at 
the Children’s Hospital in Freetown, done to validate the 
methodology and clinical data sheet, was not included in the 
study results.
Informed written consent was obtained from the parent or 
guardian of each child in the study. Approval for the study was 
obtained from the Research, Ethics and Publication Committee 
of the Faculty of Medicine of Medunsa and the Ethics 
Committee of the Sierra Leone Medical School, Freetown.
Data were entered in duplicate and analysed in Epi Info 
2000. Descriptive statistics were performed. Chi-square tests 
were done to test for association between categorical variables. 
Results
Over a 5-month period 143 children were enrolled. The initial 
enrolment target of 200 cases was not fulfilled because a strike 
by hospital staff precluded recruitment, and a number of 
gastroenteritis patients were sent home before enrolment. The 
age and gender distributions of the 128 subjects in whom stool 
samples were obtained for rotavirus testing are set out in Table 
I. There were more males (55.5%) than females, and 45.3% of 
the patients were aged between 3 and 9 months (mean age and 
median age were both 10.85 months) (standard deviation (SD) 
5.68). 
Of the 128 stool samples 48 (37.5%) tested positive for 
rotavirus; 31 (64.6%) of the rotavirus-positive cases were 
males and 17 (35.4%) were females, but the difference was 
not statistically significant (p=0.1094). Of the patients with 
rotavirus-negative results 39 (48.8%) were male. Table II 
presents the relative distribution of rotavirus infection among 
the age groups in the study. The median age for rotavirus 
infection was 8.25 months (mean 9.15 months; SD 4.81 months). 
There was an excessive number of cases of rotavirus infection 
in the two youngest age groups (3 - 9 months), in which 60% 
of the infections occurred; 36 (75.0%) of the rotavirus-positive 
children were younger than 12 months and 44 (91.6%) were 
younger than 18 months, while 66 (83.0%) of the control cases 
fell into the latter age group. The observed difference in the 
incidence of rotavirus infection between children younger than 
1 year and those older than 1 year was statistically significant 
(p=0.0338). No patient over the age of 24 months tested positive 
for rotavirus.
During July the prevalence of rotavirus-positive stools was 
52.6% (10 of 19 tests positive), in August it was 64.3% (18 of 28), 
in September it was 53.3% (8 of 15), in October it was 21.2% (7 
of 33), in November it was 18.5% (5 of 27) and in December it 
was 0% (0 of 6). These differences were statistically significant 
(p=0.0007).
 The rotavirus-positive patients all presented with diarrhoea, 
vomiting and fever, while most also had a cough or a 
cold. There was no significant difference between the two 
groups with regard to presenting symptoms or nutritional 
status (p=0.90 and 0.48). According to the Wellcome Trust 
classification of protein energy malnutrition, 77 patients 
(60.1%) were of normal weight for age, 40 (31.2%) were 
underweight for age, 4 (3.1%) had kwashiorkor, 5 (3.9%) were 
marasmic and 2 (1.6%) had marasmic kwashiorkor.
Disease severity was based on a 20-point Vesikari score 
differentiating mild, moderate and severe gastroenteritis; 43 
(89.6%) of the rotavirus-positive cases had scores of 11 and 
above (indicative of severe diarrhoea) compared with 52 (65%) 
of rotavirus-negative cases. This difference was statistically 
significant (p=0.007), and is a major finding of this study.  
More than 80% of the subjects had some dehydration, but 
severe dehydration was uncommon. There were no differences 
between the groups.
Table I. Age and gender distribution of the study 
population
         Female Male         Total
Age group (mo.)        (N (%)) (N (%))         (N (%))
3.0 - 5.99         6 (4.7) 13 (10.2)         19 (14.9)
6.0 - 8.99         19 (14.8) 20 (15.6)         39 (30.4)
9.0 - 11.99         3 (2.3) 20 (15.6)         23 (17.9)
12.0 - 17.99        20 (15.6) 9 (7.0)         29 (22.6)
18.0 - 23.99        7 (5.5) 8 (6.3)         15 (11.8)
24.0 - 29.99        2 (1.6) 1 (0.8)         3 (2.4)
   Total         57 (44.5) 71 (55.5)         128 (100)
Table II. Age group distribution of rotavirus status
        Rotavirus-neg.  Rotavirus-pos.  Total
Age group (mo.)       (N (%))           (N (%))         (N (%))
3.0 - 5.99        8 (6.2)                11 (8.6)         19 (14.8)
6.0 - 8.99        21 (16.4)            18 (14.1)         39 (30.5)
9.0 - 11.99        16 (12.5)            7 (5.5)         23 (18.0)
12.0 - 17.99       21 (16.4)            8 (6.3)         29 (22.7)
18.0 - 23.99       11 (8.6)              4 (3.1)         15 (11.7)
24.0 - 29.99       3 (2.3)                0         3 (2.3)
   Total        80 (62.5)            48 (37.5)         128 (100)
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A large number of clinical signs were elicited in both groups. 
Fever was present in 29% of rotavirus-negative versus 48% 
of rotavirus-positive subjects, oral thrush in 14% v. 21%, 
splenomegaly in 6% v. 21% and hepatomegaly in 21% v. 31%. 
In the RV-negative group, severe respiratory symptoms such 
as respiratory distress (9% v. 4%), and crepitations (19% v. 6%) 
were commoner than in the study group, while symptoms of 
cough occurred in about two-thirds of all subjects and sore 
throat (18% v. 7%) was commoner in the rotavirus-positive 
group. Cardiovascular and central nervous system symptoms 
were uncommon in both groups. Over 80% of subjects in 
both groups had general signs and symptoms of illness; 
approximately two-thirds had respiratory signs and one-third 
gastrointestinal signs (excluding diarrhoea and vomiting). 
Generally rotavirus-positive patients had more systemic signs 
and symptoms than rotavirus-negative patients, but this 
was not statistically significant. With regard to respiratory 
infections, upper respiratory tract infection (rhinitis, otitis 
media, tonsillitis, pharyngitis) was most common in both 
groups, with 21 cases (43.8%) in the rotavirus-positive group 
and 26 (32.5%) in the rotavirus-negative group. Pneumonia was 
diagnosed in less than a fifth of patients in both groups. 
The most common co-morbidities (together with 
gastroenteritis) diagnosed by the admitting physicians were 
malaria, the most common diagnosis in both groups (nearly 
90%), followed by respiratory tract infection (RTI). RTI was 
more common in the rotavirus-positive group (66.7% of cases) 
than in the rotavirus-negative group (41.3%). Other conditions, 
found in 10 patients, were typhoid fever, otitis media, anaemia, 
dermatological conditions (e.g. scabies, napkin dermatitis) 
and anaemia. Malnutrition was diagnosed by doctors in only 
4 cases. This contrasts with nutritional status based on the 
Wellcome Classification, for which figures were given above. 
The differences were not statistically significant
Discussion
The role of rotavirus as an important cause of severe diarrhoeal 
disease in young children worldwide is well established. 
However, there is much to be learnt about the epidemiology, 
clinical features and differences in the disease profiles between 
different regions of the world.
Since no previous rotavirus studies have been done in 
Sierra Leone, our finding of an incidence of 37.5% is unique. 
Incidences found in other West African countries were 33% 
in Jos, Nigeria (with a higher incidence (45%) in children 
under the age of 6 months),7 27% in Zaria, Northern Nigeria 
(again with an incidence of 45% in those under 6 months),8 
39% in Ghana and 36% in The Gambia.9 Incidence data appear 
to be similar for countries in this region. The consistency of 
these data over time and the different studies may help other 
countries in the region that do not have data to apply to the 
Global Alliance for Vaccines and Immunization for funding for 
rotavirus vaccines.
The demography of the study sample corresponds with the 
age at which the incidence of rotavirus infections is highest.4 
Rotavirus is the cause of diarrhoea in 20 - 40% of hospitalised 
children, regardless of country of origin or socio-economic 
status.10 Our finding that almost 40% of cases of diarrhoea were 
caused by rotavirus is similar to prevalences of 32%, and 36 
- 37% in hospitalised patients, in Canada.11,12 An exception is 
a study that showed a prevalence of 72% at the height of the 
rotavirus season in Canada.10 
The prevalences of diarrhoea (55.5% v. 45.5%) and rotavirus 
infection (44.3% v. 29.3%) were both higher in boys than in 
girls. This is a similar gender difference to that found in a 
Canadian study (55.6% male v. 44.4% female).12 Similar findings 
are reported from West Africa, where at times the prevalence 
of rotavirus infection is 20% higher in boys than girls, which 
corresponds to the 55%:45% differential mentioned above8 (it 
is possible that boys may be taken for medical attention more 
frequently than girls). Although these differences did not reach 
statistical significance in our study, it is intriguing that this 
gender proportion occurs in many studies.
In most countries diarrhoea occurs year-round, and this 
is also true of rotavirus infections. However, there is usually 
a well-known diarrhoea season, and within this a period of 
increased rotavirus prevalence. For example, in South Africa 
the rotavirus season has been identified in 14 studies to be 
in early autumn (March), autumn (March to May) or winter 
(June to August), while the dry season inland spans the period 
of mid-autumn to winter.13 In Botswana the rotavirus season 
was reported to be during June to August, the cool, dry winter 
season.14 In Ghana there are peaks of rotavirus prevalence in 
mid-July to September and in January to February,4,15 while 
the dry season is in July to September and in January. The 
rotavirus season is also associated with lower daily minimum 
temperatures.15 In Nigeria rotavirus is present throughout the 
year, but with a much higher prevalence in the dry season 
(October to April),4,8 with an average of 36%, than in the rainy 
season, with an average of 20%.8
In Sierra Leone and neighbouring countries the inter-tropical 
belt of cloud and rain moves southwards during the rainy 
season (May to October), when the relative humidity is also 
high.16 As temperatures hardly vary during the year there are 
no traditional summers or winters. We found that the highest 
rotavirus incidence was from July to September, with the 
peak in August, coinciding with the rainy season (average 
precipitation in June 302 mm, in July 894 mm, in August 
902 mm, in September 610 mm, and in October 310 mm).16 
Logistical and financial constraints made it impossible to 
extend the study to the period from January to June; however, 
the diarrhoea season falls during the second half of the year, 
coinciding with the rainy season (personal communication, Dr 
M A S Jalloh).
The presenting complaints of both the rotavirus-positive and 
rotavirus-negative groups included diarrhoea. Vomiting, well 
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recognised as a sign of rotavirus infection, was present in all 
our rotavirus cases, but absent in about a fifth of the rotavirus-
negative cases. The rotavirus-positive patients had more severe 
diarrhoea than those whose diarrhoea was caused by other 
pathogens, as evidenced by a higher severity score and a larger 
proportion with moderate dehydration (although the latter 
difference was not significant). Higher severity scores in a 
Ghanaian study were also associated with rotavirus infection.9 
A third of the sample was underweight for age, which 
is a common finding in Africa. The prevalence of protein 
energy malnutrition (kwashiorkor, marasmus and marasmic 
kwashiorkor) was 8.5%. While this is unacceptably high, Sierra 
Leone is a country recovering from a devastating civil war 
so this figure is perhaps not surprising. The fact that protein 
energy malnutrition was missed in 7 cases indicates that 
hospital medical staff need training in this aspect of clinical 
practice. Furthermore, the underweight-for-age group also 
needs attention.
There was no significant difference between the rotavirus 
group and the control group with regard to the various 
systemic signs. The observed signs are nonspecific indicators of 
several diseases, e.g. generalised lymphadenopathy, fever and 
pallor could be due to several infections including protozoal, 
bacterial or viral agents. Cardiovascular and central nervous 
system signs could be due to any disease condition that is 
capable of causing moderate to severe dehydration. Despite 
case reports indicating possible central nervous system 
involvement of rotavirus infection,17,18 we found very few 
central nervous system signs in our rotavirus-positive group. 
The observed changed level of consciousness in 14.7% of 
rotavirus-positive patients could be due to their dehydration 
or imbalances in their serum electrolyte levels. Clinical 
manifestations of respiratory tract infection often precede or 
coincide with rotavirus gastroenteritis in infants and children. 
Rotavirus may occasionally be one of the agents causing 
both upper and lower respiratory infections, and it has been 
suggested that rotavirus infection may be transmitted via the 
respiratory route,19 although there has been no conclusive 
evidence of such transmission.
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